Stock Compensation Plans (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended |
Apr. 01, 2023 | Mar. 26, 2022 |
Nonvested stock option activity, Weighted average exercise price | | |
Employee Benefits and Share-Based Compensation | $ 2.7 | $ 5.4 |
Restricted Stock Units | | |
Nonvested stock option activity, Nonvested options | | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance | 273,302 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | 284,818 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | (51,431) | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations | (500) | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | 506,189 | |
Nonvested stock option activity, Weighted average exercise price | | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Weighted Average Grant Date Fair Value | $ 36.39 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted, Weighted Average Grant Date Fair Value | 27.89 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | 28.23 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations, Weighted Average Grant Date Fair Value | 42.41 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Weighted Average Grant Date Fair Value | $ 32.43 | |
Performance Shares | | |
Nonvested stock option activity, Nonvested options | | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance | 364,857 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | 217,088 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | (282,256) | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations | (500) | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | 454,093 | |
Nonvested stock option activity, Weighted average exercise price | | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Weighted Average Grant Date Fair Value | $ 32.92 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted, Weighted Average Grant Date Fair Value | 33.79 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | 24.82 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations, Weighted Average Grant Date Fair Value | 42.41 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Weighted Average Grant Date Fair Value | $ 35.60 | |
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Other | 154,904 | |
Adjusted for performance results achieved | $ 24.84 | |
Performance Shares | MegaGrant | | |
Nonvested stock option activity, Nonvested options | | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance | 840,926 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | 0 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 0 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations | (37,500) | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | 803,426 | |
Nonvested stock option activity, Weighted average exercise price | | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Weighted Average Grant Date Fair Value | $ 21.77 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted, Weighted Average Grant Date Fair Value | 0 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | 0 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations, Weighted Average Grant Date Fair Value | 19.97 | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Weighted Average Grant Date Fair Value | $ 21.86 | |
Share-based Payment Arrangement, Option [Member] | | |
Nonvested stock option activity, Weighted average exercise price | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 239,564 | |
Weighted average exercise price (in dollars per share) | $ 9.54 | |
Share-based Payment Arrangement, Option [Member] | Exercise Price, Range One [Member] | | |
Nonvested stock option activity, Weighted average exercise price | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 185,000 | |
Weighted average exercise price (in dollars per share) | $ 8.80 | |
Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term | 8 months 12 days | |
Share-based Payment Arrangement, Option [Member] | Exercise Price, Range Two [Member] | | |
Nonvested stock option activity, Weighted average exercise price | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 54,564 | |
Weighted average exercise price (in dollars per share) | $ 11.97 | |
Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term | 8 months 12 days | |